Suppr超能文献

基于氮鎓离子稳定性的局部定量构效关系模型,以支持国际人用药品注册技术协调会(ICH)M7专家对伯芳香胺致突变性的审评。

A local QSAR model based on the stability of nitrenium ions to support the ICH M7 expert review on the mutagenicity of primary aromatic amines.

作者信息

Furukawa Ayaka, Ono Satoshi, Yamada Katsuya, Torimoto Nao, Asayama Mahoko, Muto Shigeharu

机构信息

Safety Research Laboratories, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan.

Discovery Technology Laboratories, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa, 227-0033, Japan.

出版信息

Genes Environ. 2022 Mar 21;44(1):10. doi: 10.1186/s41021-022-00238-1.

Abstract

BACKGROUND

Aromatic amines, often used as intermediates for pharmaceutical synthesis, may be mutagenic and therefore pose a challenge as metabolites or impurities in drug development. However, predicting the mutagenicity of aromatic amines using commercially available, quantitative structure-activity relationship (QSAR) tools is difficult and often requires expert review. In this study, we developed a shareable QSAR tool based on nitrenium ion stability.

RESULTS

The evaluation using in-house aromatic amine intermediates revealed that our model has prediction accuracy of aromatic amine mutagenicity comparable to that of commercial QSAR tools. The effect of changing the number and position of substituents on the mutagenicity of aromatic amines was successfully explained by the change in the nitrenium ion stability. Furthermore, case studies showed that our QSAR tool can support the expert review with quantitative indicators.

CONCLUSIONS

This local QSAR tool will be useful as a quantitative support tool to explain the substituent effects on the mutagenicity of primary aromatic amines. By further refinement through method sharing and standardization, our tool can support the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) M7 expert review with quantitative indicators.

摘要

背景

芳香胺常用作药物合成中间体,可能具有致突变性,因此在药物研发中作为代谢物或杂质构成挑战。然而,使用市售的定量构效关系(QSAR)工具预测芳香胺的致突变性很困难,且通常需要专家评审。在本研究中,我们基于氮宾离子稳定性开发了一种可共享的QSAR工具。

结果

使用内部芳香胺中间体进行评估表明,我们的模型对芳香胺致突变性的预测准确性与市售QSAR工具相当。通过氮宾离子稳定性的变化成功解释了取代基数量和位置变化对芳香胺致突变性的影响。此外,案例研究表明,我们的QSAR工具可以用定量指标支持专家评审。

结论

这种局部QSAR工具将作为一种定量支持工具,用于解释取代基对伯芳香胺致突变性的影响。通过方法共享和标准化进一步完善,我们的工具可以用定量指标支持人用药品注册技术协调国际会议(ICH)M7专家评审。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ab/8935809/a671c3b95180/41021_2022_238_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验